Pacific Biosciences Of California (PACB) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134.36% |
| Dec 31, 2025 | -1.94% |
| Sep 30, 2025 | 36.32% |
| Jun 30, 2025 | 33.32% |
| Mar 31, 2025 | -43.74% |
| Dec 31, 2024 | 32.58% |
| Sep 30, 2024 | 16.22% |
| Jun 30, 2024 | 28.30% |
| Mar 31, 2024 | -31.48% |
| Dec 31, 2023 | 11.69% |
| Sep 30, 2023 | -56.16% |
| Jun 30, 2023 | 55.92% |
| Mar 31, 2023 | -56.34% |
| Dec 31, 2022 | 3.94% |
| Sep 30, 2022 | -4.11% |
| Jun 30, 2022 | 23.37% |
| Mar 31, 2022 | -149.24% |
| Jun 30, 2021 | 31.99% |
| Mar 31, 2021 | -61.99% |
| Dec 31, 2020 | 19.91% |
| Sep 30, 2020 | 25.14% |
| Jun 30, 2020 | -131.57% |
| Mar 31, 2020 | 514.54% |
| Dec 31, 2019 | -5.33% |
| Sep 30, 2019 | 1.70% |
| Jun 30, 2019 | 30.63% |
| Mar 31, 2019 | -33.33% |
| Dec 31, 2018 | -33.93% |
| Sep 30, 2018 | 2.22% |
| Jun 30, 2018 | 22.78% |
| Mar 31, 2018 | 7.06% |
| Dec 31, 2017 | -13.24% |
| Sep 30, 2017 | -39.26% |
| Jun 30, 2017 | 23.17% |
| Mar 31, 2017 | -29.22% |
| Dec 31, 2016 | 18.74% |
| Sep 30, 2016 | 15.93% |
| Jun 30, 2016 | 6.82% |
| Mar 31, 2016 | -2,738.52% |
| Dec 31, 2015 | 95.47% |
| Sep 30, 2015 | -110.44% |
| Jun 30, 2015 | 68.66% |
| Mar 31, 2015 | -55.70% |
| Dec 31, 2014 | -146.30% |
| Sep 30, 2014 | 54.22% |
| Jun 30, 2014 | 16.22% |
| Mar 31, 2014 | -11.54% |
| Dec 31, 2013 | -177.84% |
| Sep 30, 2013 | 214.12% |
| Jun 30, 2013 | 6.65% |
| Mar 31, 2013 | 3.56% |
| Dec 31, 2012 | -3.25% |
| Sep 30, 2012 | 25.25% |
| Jun 30, 2012 | -36.19% |
| Mar 31, 2012 | -17.37% |
| Dec 31, 2011 | 38.07% |
| Sep 30, 2011 | 22.79% |
| Jun 30, 2011 | 7.67% |
| Mar 31, 2011 | 14.31% |
| Dec 31, 2010 | -17.07% |